SciELO - Scientific Electronic Library Online

 
vol.8 número2Estudio comparativo entre la vía vaginal y la abdominal en la presentación pelviana a términoProblemas clínicos durante el mantenimiento del donante potencial de órganos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista de Ciencias Médicas de Pinar del Río

versão On-line ISSN 1561-3194

Resumo

RODRIGUEZ VAZQUEZ, Belkis et al. Misoprostol to the early abortion in adolescence. Rev Ciencias Médicas [online]. 2004, vol.8, n.2, pp. 74-82. ISSN 1561-3194.

Abortion in adolescence continues to be a worldwide problem. That is why effective methods should be found to diminish morbidity and mortality due to its cause. Misoprostol would help to solve this health problem. Misoprostol (800 mcg) was used per vaginam and patients were followed sonographically repeating dosages when necessary up to three times. This method was used in 212 adolescents who attended to Abel Santamaría Hospital for abortion. These patients met all requirements and the method was used showing its safety and effectiveness. The average age was 17.1 years having a deviation of 1.2 years, the mean pregnancy time was 7 weeks, most of the patients were single (75.7 %). Side effects were: pain (90 %), diarrhea (33.7 %), headache (17.4 %) among others. The best expulsion stage was 6 to 8 hours (91.7 %). Patients having an endometrium > 24 mm (3.3 %) suffered from bleeding for more than 14 days without complications (there was no need of blood transfusion or curettage). The best effectiveness was obtained in patients between 7 and 10 weeks of pregnancy and the total effectiveness of the method was 99.05 % despite the first dosage was 97.64 %.

Palavras-chave : MISOPROSTOL [therapeutic use].

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License